Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Pro: Can biomarkers be gold standards in Alzheimer's disease?

    Sperling R, Johnson K.

    Alzheimers Res Ther. 2010 Jun 25;2(3):17.

    PMID:
    20587006
    [PubMed]
    Free PMC Article
    2.

    Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

    Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

    Alzheimers Dement. 2008 Jan;4(1):38-48. Epub 2007 Dec 21. Review.

    PMID:
    18631949
    [PubMed - indexed for MEDLINE]
    3.

    PET amyloid-beta imaging in preclinical Alzheimer's disease.

    Vlassenko AG, Benzinger TL, Morris JC.

    Biochim Biophys Acta. 2012 Mar;1822(3):370-9. Epub 2011 Nov 12.

    PMID:
    22108203
    [PubMed - in process]
    4.

    Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

    Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

    Alzheimers Dement. 2011 May;7(3):280-92. Epub 2011 Apr 21.

    PMID:
    21514248
    [PubMed - in process]
    5.

    Diagnosis and biomarkers of predementia in Alzheimer's disease.

    Forlenza OV, Diniz BS, Gattaz WF.

    BMC Med. 2010 Dec 22;8:89. Review.

    PMID:
    21176189
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Biomarkers in preclinical Alzheimer's disease.

    Chong MS, Lim WS, Sahadevan S.

    Curr Opin Investig Drugs. 2006 Jul;7(7):600-7. Review.

    PMID:
    16869111
    [PubMed - indexed for MEDLINE]
    7.

    Biomarkers predicting Alzheimer's disease in cognitively normal aging.

    Shim YS, Morris JC.

    J Clin Neurol. 2011 Jun;7(2):60-8. Epub 2011 Jun 28.

    PMID:
    21779293
    [PubMed]
    Free PMC Article
    8.

    Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

    Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

    Alzheimers Dement. 2010 May;6(3):230-8. Review.

    PMID:
    20451871
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Biomarkers of mild cognitive impairment and Alzheimer's disease.

    Tang BL, Kumar R.

    Ann Acad Med Singapore. 2008 May;37(5):406-10.

    PMID:
    18536828
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

    Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC.

    Brain. 2007 Mar;130(Pt 3):731-9. Epub 2007 Jan 31.

    PMID:
    17267522
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    CSF Biomarkers for Alzheimer's Disease Diagnosis.

    Anoop A, Singh PK, Jacob RS, Maji SK.

    Int J Alzheimers Dis. 2010 Jun 23;2010. pii: 606802.

    PMID:
    20721349
    [PubMed]
    Free PMC Article
    12.

    [Current topics about mild cognitive impairment (MCI)].

    Yamamoto Y.

    Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.

    PMID:
    21815470
    [PubMed - indexed for MEDLINE]
    13.

    Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment.

    Apostolova LG, Thompson PM.

    Neuropsychologia. 2008;46(6):1597-612. Epub 2007 Dec 14. Review.

    PMID:
    18395760
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    [Predementia Alzheimer's disease. Benefits of early diagnosis].

    Viloria A.

    Rev Esp Geriatr Gerontol. 2011 Oct;46 Suppl 1:47-54. Spanish.

    PMID:
    22152916
    [PubMed - in process]
    15.

    The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.

    Schneider LS.

    J Nutr Health Aging. 2010 Apr;14(4):295-8.

    PMID:
    20305999
    [PubMed - indexed for MEDLINE]
    16.

    Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.

    Dickerson BC, Sperling RA.

    NeuroRx. 2005 Apr;2(2):348-60. Review.

    PMID:
    15897955
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Biomarkers in translational research of Alzheimer's disease.

    Tarawneh R, Holtzman DM.

    Neuropharmacology. 2010 Sep-Oct;59(4-5):310-22. Epub 2010 Apr 13. Review.

    PMID:
    20394760
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia.

    Stefani A, Sancesario G, Pierantozzi M, Leone G, Galati S, Hainsworth AH, Diomedi M.

    J Neurol Sci. 2009 Aug 15;283(1-2):109-15. Epub 2009 Mar 10.

    PMID:
    19278690
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk